Quarterly activities report for July September 2017 – The quarterly activities include details of monitoring and compliance activities by the Office of the Gene Technology Regulator (OGTR) during the quarter. Monitoring of GMO Dealings involving Intentional Release (DIR) During the quarter OGTR inspected 7 GM plant field trial sites (Table 1). The inspections comprised: Current field trial sites Of the 37 sites current in the quarter, 3 were inspected. As these – three sites had never been visited before by OGTR they were selected for a routine, announced inspection to assess compliance with licence conditions. Post-harvest field trial sites Of the 59 sites subject to post-harvest monitoring in the – quarter, 4 were inspected. The two Victorian sites were selected for inspection to assist OGTR in assessing the licence holders request for sign-off from monitoring obligations. Table 1 Summary of inspection activities of GM crop field trials for the July September – – 2017 quarter. Licence holder Licence GM Crop Site location Number (crop status1) Department of Primary DIR 047 White Clover Southern Grampians (1P) Industries Victoria DIR 103 Canola Horsham (1P) Go Resources Pty Ltd DIR 131 Safflower Wyndham-East Kimberley (2C, 2P) Monsanto Australia Ltd DIR 147 Cotton Wyndham-East Kimberley (1C) 1C = current site, P = post-harvest site Monitoring of GMO Dealings Not involving Intentional Release (DNIR), certified facilities and DIR clinical trials During the quarter OGTR inspected 6 organisations holding certified facilities (Table 2), 2 undertaking DNIR licences and undertaking a DIR clinical trial (Table 1 3). These inspections were all routine and announced. Authorisations were selected based on a range of considerations including time since they were last inspected, relevant compliance history and the specific risks associated with the authorisations. Table 2 Summary of organisations and facility types that the OGTR inspected for the July – – September 2017 quarter.
Quarterly activities report for July – September 2017 The quarterly activities include details of monitoring and compliance activities by the Office of the Gene Technology Regulator (OGTR) during the quarter. Monitoring of GMO Dealings involving Intentional Release (DIR) During the quarter OGTR inspected 7 GM plant field trial sites (Table 1). The inspections comprised: Current field trial sites – Of the 37 sites current in the quarter, 3 were inspected. As these three sites had never been visited before by OGTR they were selected for a routine, announced inspection to assess compliance with licence conditions. Post-harvest field trial sites – Of the 59 sites subject to post-harvest monitoring in the quarter, 4 were inspected. The two Victorian sites were selected for inspection to assist OGTR in assessing the licence holders request for sign-off from monitoring obligations. Table 1 – Summary of inspection activities of GM crop field trials for the July – September 2017 quarter. Licence holder Licence Number GM Crop Site location (crop status1) Department of Primary Industries Victoria DIR 047 DIR 103 White Clover Canola Southern Grampians (1P) Horsham (1P) Go Resources Pty Ltd DIR 131 Safflower Wyndham-East Kimberley (2C, 2P) Monsanto Australia Ltd DIR 147 Cotton Wyndham-East Kimberley (1C) 1C = current site, P = post-harvest site Monitoring of GMO Dealings Not involving Intentional Release (DNIR), certified facilities and DIR clinical trials During the quarter OGTR inspected 6 organisations holding certified facilities (Table 2), 2 undertaking DNIR licences and 1 undertaking a DIR clinical trial (Table 3). These inspections were all routine and announced. Authorisations were selected based on a range of considerations including time since they were last inspected, relevant compliance history and the specific risks associated with the authorisations. Table 2 – Summary of organisations and facility types that the OGTR inspected for the July – September 2017 quarter.
Quarterly%20activities%20report%20for%20July%20-%20September%202017.docx